The effect of N-cycloalkylation on the cardiovascular activity of noradrenalone.
D000315:Adrenalectomy; D018663:Adrenergic Agents / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D003516:Cycloparaffins / Q000494:pharmacology*; D004837:Epinephrine / Q000378:metabolism; D006321:Heart / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007659:Ketones / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011941:Receptors, Adrenergic / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D013116:Spinal Cord / Q000502:physiology; D013154:Spleen / Q000187:drug effects; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D013566:Sympathomimetics / Q000494:pharmacology*
D018663:Adrenergic Agents; D002395:Catecholamines; D003516:Cycloparaffins; D007659:Ketones; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D012110:Reserpine; D009638:Norepinephrine; D004837:Epinephrine